Jazz Pharma Still Loved At UBS, Firm Hikes Price Target To $210
June 29, 2015 at 11:11 AM EDT
In a report published Monday, UBS analyst Marc Goodman maintained a Buy rating on Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.